Jul 20, 2021 Becton Dickinson (NYSE: BDX) has entered into an agreement to acquire needle-free blood draw company Velano Vascular.
A prolonged stay in a hospital can be taxing even without repeated blood draws to monitor a person’s condition. Becton Dickinson plans to make that part of the process a little easier, through the acquisition of Velano Vascular.
Becton Dickinson is based at Franklin Lakes, New Jersey, United States. “BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care.”
Acquirer’s Website: www.bd.com
Velano Vascular is based in San Francisco, California, United States. “Establishing a new standard of care for inpatient blood draws by improving the experience and reducing pain, risks and inefficiencies of existing practices.”
Acquirer’s Website: velanovascular.com